| Synonyms: | |
| Status: | Approved (2000) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 2494G1JF75 |
| InChI Key | KJHKTHWMRKYKJE-SUGCFTRWSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C37H48N4O5 |
| Molecular Weight | 628.81 |
| AlogP | 4.33 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 15.0 |
| Polar Surface Area | 120.0 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 46.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Human immunodeficiency virus type 1 protease inhibitor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| HIV Infections | 4 | D015658 | ClinicalTrials |
| Coronavirus Infections | 3 | D018352 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome | 3 | D000163 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Pneumonia | 3 | D011014 | ClinicalTrials |
| Coronavirus Infections | 3 | D018352 | ClinicalTrials |
| Influenza, Human | 3 | D007251 | ClinicalTrials |
| Sarcoma, Kaposi | 2 | D012514 | ClinicalTrials |
| Pregnancy | 2 | D011247 | ClinicalTrials |
| Infections | 2 | D007239 | ClinicalTrials |
| Tuberculosis | 1 | D014376 | ClinicalTrials |
| Hepatitis C | 1 | D006526 | ClinicalTrials |
| Insulin Resistance | 1 | D007333 | ClinicalTrials |
| Respiratory Distress Syndrome | 1 | D012128 | ClinicalTrials |
| Anus Neoplasms | 1 | D001005 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 192725-17-0 |
| ChEBI | 31781 |
| ChEMBL | CHEMBL729 |
| DrugBank | DB01601 |
| DrugCentral | 1601 |
| EPA CompTox | DTXSID8046456 |
| FDA SRS | 2494G1JF75 |
| Human Metabolome Database | HMDB15539 |
| KEGG | C12871 |
| PDB | AB1 |
| PharmGKB | PA450264 |
| PubChem | 92727 |
| SureChEMBL | SCHEMBL21775 |
| ZINC | ZINC000003951740 |